Results 201 to 210 of about 51,702 (268)

CT and Fluorine-18-Fluorodeoxyglucose (18F-FDG) PET/CT Imaging Findings of Aggressive Systemic Mastocytosis: A Case Report. [PDF]

Cureus
Sato M, Kurokawa R, Okimoto N, Tokushige J, Ikemura M, Abe O.   +5 more
europepmc   +1 more source

Simple and Efficient Synthesis of N-Succinimidyl-4-[¹⁸F]fluorobenzoate ([¹⁸F]SFB)-An Important Intermediate for the Introduction of Fluorine-18 into Complex Bioactive Compounds. [PDF]

Pharmaceuticals (Basel)
Orlovskaya VV, Fedorova OS, Viktorov NB, Krasikova RN.   +3 more
europepmc   +1 more source

Synthesis and Biological Evaluation of Fluorine-18 and Deuterium Labeled l-Fluoroalanines as Positron Emission Tomography Imaging Agents for Cancer Detection. [PDF]

J Med Chem
Li K, Gilberti AL, Marden JA, Akula HK, Pollard AC, Guo S, Hu B, Tonge PJ, Qu W.   +8 more
europepmc   +1 more source

In Vivo Reactive Astrocyte Imaging in Patients With Schizophrenia Using Fluorine 18-Labeled THK5351.

JAMA Netw Open
Kim M, Choi W, Choi S, Oh H, Kim J, Lee J, An SJ, Hwang JS, Lee YS, Song IC, Moon SY, Lho SK, Cho SS, Kwon JS.   +13 more
europepmc   +1 more source

Fluorine-18 FDG PET/CT and New NIMS Grading System for Chemotherapy Response in Breast Cancer. [PDF]

Indian J Nucl Med
Vakati GR, Ratnagiri R, Srivastava MK.
europepmc   +1 more source

Fluorine-18 Prostate-Specific Membrane Antigen-1007 PET/CT vs Multiparametric MRI for Locoregional Staging of Prostate Cancer.

JAMA Oncol
Mookerji N, Pfanner T, Hui A, Huang G, Albers P, Mittal R, Broomfield S, Dean L, St Martin B, Jacobsen NE, Evans H, Gao Y, Hung R, Abele J, Dromparis P, Lima JF, Bismar T, Michelakis E, Sutendra G, Wuest F, Tu W, Adam BA, Fung C, Tamm A, Kinnaird A.   +24 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Production of reactive fluorine-18

International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986
Production conditions are reviewed from the perspective of maximizing activity--both total and specific--of 18F as electrophilic or nucleophilic precursors, with minimal levels of interfering species. Careful target design can avoid many pitfalls, and telemetry of a few key variables can guide the way to reproducible yields, consistent with prediction.
R J, Nickles, S J, Gatley, J R, Votaw, M L, Kornguth   +3 more
openaire   +2 more sources

The Preparation of Fluorine-18 Labelled Radiopharmaceuticals

The International Journal of Applied Radiation and Isotopes, 1977
Abstract Progress in the preparation of fluorine-18 labelled radiopharmaceuticals is reviewed. The pharmacology and design of 18F-labelled organic compounds of biomedical interest, production of the radionuclide and methods of labelling which have been used to date are discussed. Emphasis has been placed on the practical chemical problems encountered,
A K, Horsch, K, Hudson, R W, Goulding, A J, Day   +3 more
openaire   +2 more sources

Recommendations for fluorine-18 production [PDF]

International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1991
Abstract Data for the production of fluorine-18 (t 1/2 = 109.6 min; β + = 100%) are reviewed. The experience of some well-established European centres for positron emission tomography (PET), in the routine production of fluorine-18 for the purpose of labelling radiopharmaceuticals, is described.
Guillaume, Marcel, Luxen, André, Nebeling, Bruno, Argentini, Mario, Clark, John W., Pike, Victor William   +5 more
openaire   +1 more source

Therapy Monitoring with Fluorine-18 FDG-PET and Fluorine-18 FDG-PET/CT

PET Clinics, 2008
PET with the glucose analog [18F]-FDG is increasingly used to monitor tumor response in patients undergoing chemotherapy and chemoradiotherapy. The clinical value of FDG PET for differentiation of residual tumor and therapy-induced fibrosis has been documented for gastrointestinal cancer.
Hinrich A, Wieder, Ken, Herrmann
openaire   +2 more sources